260 related articles for article (PubMed ID: 21181914)
1. The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination.
Melgaço JG; Pinto MA; Rocha AM; Freire M; Gaspar LP; Lima SM; Cruz OG; Vitral CL
J Med Virol; 2011 Feb; 83(2):208-17. PubMed ID: 21181914
[TBL] [Abstract][Full Text] [Related]
2. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.
Barkai G; Belmaker I; Givon-Lavi N; Dagan R
Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis A antibodies in schoolchildren in Catalonia (Spain) after the introduction of universal hepatitis A immunization.
Domínguez A; Bruguera M; Plans P; Costa J; Salleras L
J Med Virol; 2004 Jun; 73(2):172-6. PubMed ID: 15122789
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children.
Al-Aziz AM; Awad MA
East Mediterr Health J; 2008; 14(5):1028-35. PubMed ID: 19161074
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
[TBL] [Abstract][Full Text] [Related]
6. Rapid antibody response after vaccination with a virosomal hepatitis a vaccine.
Ambrosch F; Finkel B; Herzog C; Koren A; Kollaritsch H
Infection; 2004 Jun; 32(3):149-52. PubMed ID: 15188074
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly.
D'Acremont V; Herzog C; Genton B
J Travel Med; 2006; 13(2):78-83. PubMed ID: 16553593
[TBL] [Abstract][Full Text] [Related]
8. Initial evaluation of universal immunization with a single dose against hepatitis A virus in Central Brazil.
Brito WI; Alves-Junior ER; Oliveira RM; Souto FJD
Braz J Infect Dis; 2018; 22(3):166-170. PubMed ID: 29684320
[TBL] [Abstract][Full Text] [Related]
9. Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years.
Van Herck K; Jacquet JM; Van Damme P
J Med Virol; 2011 Nov; 83(11):1885-91. PubMed ID: 21915861
[TBL] [Abstract][Full Text] [Related]
10. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
12. Is vaccination against hepatitis A virus required in patients with cirrhosis of the liver?
Duseja A; Sharma S; Das K; Dhiman RK; Chawla YK
Trop Gastroenterol; 2004; 25(4):162-3. PubMed ID: 15912973
[TBL] [Abstract][Full Text] [Related]
13. Cell mediated and antibody immune response to inactivated hepatitis A vaccine.
Schmidtke P; Habermehl P; Knuf M; Meyer CU; Sänger R; Zepp F
Vaccine; 2005 Oct; 23(44):5127-32. PubMed ID: 16054733
[TBL] [Abstract][Full Text] [Related]
14. Serological study of hepatitis A virus infection amongst the students of a medical college in Delhi & evaluation of the need of vaccination.
Jindal M; Rana SS; Gupta RK; Das K; Kar P
Indian J Med Res; 2002 Jan; 115():1-4. PubMed ID: 12424929
[TBL] [Abstract][Full Text] [Related]
15. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
[TBL] [Abstract][Full Text] [Related]
17. Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults.
Hammitt LL; Bulkow L; Hennessy TW; Zanis C; Snowball M; Williams JL; Bell BP; McMahon BJ
J Infect Dis; 2008 Dec; 198(12):1776-82. PubMed ID: 18976095
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
[TBL] [Abstract][Full Text] [Related]
19. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
[TBL] [Abstract][Full Text] [Related]
20. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?
Anand AC; Nagpal AK; Seth AK; Dhot PS
J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
